[1]
V. S. Bebarta, MD, FACEP, FACMT, N. Garrett, PhD, S. Boudreau, RN, BSN, and M. Castaneda, MS, “Intraosseous hydroxocobalamin versus intravenous hydroxocobalamin compared to intraosseous whole blood or no treatment for hemorrhagic shock in a swine model”, Am J Disaster Med, vol. 10, no. 3, pp. 205–215, Jul. 2015.